|
Market Closed -
Nasdaq
23:00:00 14/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 209.83 USD | -0.39% |
|
+0.91% | +19.23% |
| 08-13 | Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300 | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
